Arpad Simon, M.D., has been appointed to the role of vice president of pharmacovigilance at AMAG Pharmaceuticals. Dr. Simon will have responsibility for all pharmacovigilance functions at AMAG, including product safety surveillance, aggregate safety reporting and risk management. He will also oversee safety evaluation across the company’s clinical development activities and marketed therapeutics.   Dr. Simon has more than 20 years of pharmaceutical industry experience with extensive operationa...